Finance

Lists
2196:HKG
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
17,11 HKD
-0,23%
(-0,040) 1D
16 ოქტ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2196...
Open
17,32 HKD
High
17,55 HKD
Low
16,88 HKD
Mkt. cap
66,13 მლრდ.
Avg. vol.
3,62 მლნ.
Volume
2,25 მლნ.
Dividend
2,63%
Quarterly dividend
0,11 HKD
Ex-dividend date
27 ივლ. 2026
P/E ratio
11,33
52-wk high
24,84 HKD
52-wk low
14,90 HKD
EPS
1,51 HKD
Shares outstanding
551,94 მლნ.
No. of employees
41 ათ.
Open
17,32 HKD
High
17,55 HKD
Low
16,88 HKD
Mkt. cap
66,13 მლრდ.
Avg. vol.
3,62 მლნ.
Volume
2,25 მლნ.
Dividend
2,63%
Quarterly dividend
0,11 HKD
Ex-dividend date
27 ივლ. 2026
P/E ratio
11,33
52-wk high
24,84 HKD
52-wk low
14,90 HKD
EPS
1,51 HKD
Shares outstanding
551,94 მლნ.
No. of employees
41 ათ.
News stories
From web sources and news partners
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOლიუ აი | ვენ დეიონგ
Employees40,7 ათ.
Founded1994
Headquarters-
SectorPharmaceutical industry
Websitefosunpharma.com
Last report
25 აგვ. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (CNY)
10,37 მლრდ. / 10,66 მლრდ.
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
9,88 მლრდ.
12,27 მლრდ.
10,07 მლრდ.
10,37 მლრდ.
Cost of goods sold
5,08 მლრდ.
5,65 მლრდ.
5,07 მლრდ.
5,23 მლრდ.
Cost of revenue
5,08 მლრდ.
5,65 მლრდ.
5,07 მლრდ.
5,23 მლრდ.
Research and development expenses
1,01 მლრდ.
1,28 მლრდ.
896,79 მლნ.
1,19 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,10 მლრდ.
4,44 მლრდ.
3,27 მლრდ.
3,35 მლრდ.
Operating expense
4,04 მლრდ.
5,92 მლრდ.
4,19 მლრდ.
4,63 მლრდ.
Total operating expenses
9,12 მლრდ.
11,57 მლრდ.
9,26 მლრდ.
9,86 მლრდ.
Operating income
758,38 მლნ.
699,05 მლნ.
813,78 მლნ.
505,27 მლნ.
Other non operating income
-116,85 მლნ.
107,33 მლნ.
2,03 მლნ.
-13,28 მლნ.
EBT including unusual items
1,12 მლრდ.
1,27 მლრდ.
1,36 მლრდ.
1,23 მლრდ.
EBT excluding unusual items
1,49 მლრდ.
1,10 მლრდ.
1,21 მლრდ.
1,07 მლრდ.
Income tax expense
162,98 მლნ.
82,80 მლნ.
277,92 მლნ.
159,73 მლნ.
Effective tax rate
14,57%
6,50%
20,47%
13,00%
Other operating expenses
-92,19 მლნ.
117,57 მლნ.
19,04 მლნ.
74,01 მლნ.
Net income
821,33 მლნ.
847,27 მლნ.
870,83 მლნ.
850,64 მლნ.
Net profit margin
8,31%
6,91%
8,64%
8,20%
Earnings per share
-
-
-
-
Interest and investment income
1,05 მლრდ.
732,13 მლნ.
689,67 მლნ.
938,86 მლნ.
Interest expense
-321,25 მლნ.
-291,32 მლნ.
-296,51 მლნ.
-310,88 მლნ.
Net interest expenses
727,28 მლნ.
440,80 მლნ.
393,16 მლნ.
627,98 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,39 მლრდ.
1,47 მლრდ.
1,59 მლრდ.
1,24 მლრდ.
Gain or loss from assets sale
2,12 მლნ.
-69,35 მლნ.
-
-195,23 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები